-
1
-
-
0028657630
-
Coagulopathies of liver diseases
-
Mammen E.F. Coagulopathies of liver diseases. Clin Lab Med 14 (1994) 769-780
-
(1994)
Clin Lab Med
, vol.14
, pp. 769-780
-
-
Mammen, E.F.1
-
2
-
-
0028258375
-
Coagulation defects in liver diseases
-
Mammen E.F. Coagulation defects in liver diseases. Med Clin North Am 78 (1994) 545-554
-
(1994)
Med Clin North Am
, vol.78
, pp. 545-554
-
-
Mammen, E.F.1
-
3
-
-
0026467337
-
Coagulation abnormalities in liver diseases
-
Mammen E.F. Coagulation abnormalities in liver diseases. Hematol Oncol Clin North Am 8 (1992) 1247-1257
-
(1992)
Hematol Oncol Clin North Am
, vol.8
, pp. 1247-1257
-
-
Mammen, E.F.1
-
6
-
-
21344460746
-
The role of thrombopoietin in the thrombocytopenia of patients with liver cirrhosis
-
Rios R., Sangro B., Herrero I., et al. The role of thrombopoietin in the thrombocytopenia of patients with liver cirrhosis. Am J Gastroenterol 100 (2005) 1311-1316
-
(2005)
Am J Gastroenterol
, vol.100
, pp. 1311-1316
-
-
Rios, R.1
Sangro, B.2
Herrero, I.3
-
7
-
-
0344064996
-
Relationship between thrombopoietin serum levels and liver function in patients with chronic liver disease related to hepatitis C virus infection
-
Giannini E., Botta F., Borro P., et al. Relationship between thrombopoietin serum levels and liver function in patients with chronic liver disease related to hepatitis C virus infection. Am J Gastroenterol 98 (2003) 2516-2520
-
(2003)
Am J Gastroenterol
, vol.98
, pp. 2516-2520
-
-
Giannini, E.1
Botta, F.2
Borro, P.3
-
8
-
-
0036845812
-
Serum thrombopoietin levels are linked to liver function in untreated patients with hepatitis C virus-related chronic hepatitis
-
Giannini E., Borro P., Botta F., et al. Serum thrombopoietin levels are linked to liver function in untreated patients with hepatitis C virus-related chronic hepatitis. J Hepatol 37 (2002) 572-577
-
(2002)
J Hepatol
, vol.37
, pp. 572-577
-
-
Giannini, E.1
Borro, P.2
Botta, F.3
-
9
-
-
0036841403
-
Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis, and its relationship with circulating thrombocyte counts
-
Koruk M., Onuk M.D., Akcay F., et al. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis, and its relationship with circulating thrombocyte counts. Hepatogastroenterology 49 (2002) 1645-1648
-
(2002)
Hepatogastroenterology
, vol.49
, pp. 1645-1648
-
-
Koruk, M.1
Onuk, M.D.2
Akcay, F.3
-
10
-
-
0033015909
-
Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis
-
Kawasaki T., Takeshita A., Souda K., et al. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis. Am J Gastroenterol 94 (1999) 1918-1922
-
(1999)
Am J Gastroenterol
, vol.94
, pp. 1918-1922
-
-
Kawasaki, T.1
Takeshita, A.2
Souda, K.3
-
11
-
-
0036376859
-
Serum thrombopoietin in chronic liver disease: relation to severity of the disease and spleen size
-
Freni M.A., Spadaro A., Ajello A., et al. Serum thrombopoietin in chronic liver disease: relation to severity of the disease and spleen size. Hepatogastroenterology 49 (2002) 1382-1385
-
(2002)
Hepatogastroenterology
, vol.49
, pp. 1382-1385
-
-
Freni, M.A.1
Spadaro, A.2
Ajello, A.3
-
12
-
-
0036267737
-
Thrombopoietin serum levels are elevated in patients with hepatitis B/C infection compared to other causes of chronic liver disease
-
Schoffski P., Tacke F., Trautwein C., et al. Thrombopoietin serum levels are elevated in patients with hepatitis B/C infection compared to other causes of chronic liver disease. Liver 22 (2002) 114-120
-
(2002)
Liver
, vol.22
, pp. 114-120
-
-
Schoffski, P.1
Tacke, F.2
Trautwein, C.3
-
13
-
-
0037263550
-
Thrombopoietin levels and peripheral platelet counts following living related donor liver transplantation
-
Tsukahara A., Sato Y., Yamamoto S., et al. Thrombopoietin levels and peripheral platelet counts following living related donor liver transplantation. Hepatogastroenterology 50 (2003) 227-230
-
(2003)
Hepatogastroenterology
, vol.50
, pp. 227-230
-
-
Tsukahara, A.1
Sato, Y.2
Yamamoto, S.3
-
14
-
-
12944249537
-
Thrombopoietin induces rapid resolution of thrombocytopenia after orthotopic liver transplantation through increased platelet production
-
Peck-Radosavljevic M., Wichlas M., Zacherl J., et al. Thrombopoietin induces rapid resolution of thrombocytopenia after orthotopic liver transplantation through increased platelet production. Blood 95 (2000) 795-801
-
(2000)
Blood
, vol.95
, pp. 795-801
-
-
Peck-Radosavljevic, M.1
Wichlas, M.2
Zacherl, J.3
-
15
-
-
0033042073
-
Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation
-
Goulis J., Chau T.N., Jordan S., et al. Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation. Gut 44 (1999) 754-758
-
(1999)
Gut
, vol.44
, pp. 754-758
-
-
Goulis, J.1
Chau, T.N.2
Jordan, S.3
-
16
-
-
0032910590
-
Thrombopoietic cytokines and reversal of thrombocytopenia after liver transplantation
-
Peck-Radosavljevic M., Zacherl J., Wichlas M., et al. Thrombopoietic cytokines and reversal of thrombocytopenia after liver transplantation. Eur J Gastroenterol Hepatol 11 (1999) 151-156
-
(1999)
Eur J Gastroenterol Hepatol
, vol.11
, pp. 151-156
-
-
Peck-Radosavljevic, M.1
Zacherl, J.2
Wichlas, M.3
-
17
-
-
0030818789
-
Thrombopoietin levels in patients with cirrhosis before and after orthotopic liver transplantation
-
Martin III T.G., Somberg K.A., Meng Y.G., et al. Thrombopoietin levels in patients with cirrhosis before and after orthotopic liver transplantation. Ann Intern Med 127 (1997) 285-288
-
(1997)
Ann Intern Med
, vol.127
, pp. 285-288
-
-
Martin III, T.G.1
Somberg, K.A.2
Meng, Y.G.3
-
18
-
-
0036678345
-
Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection
-
Pockros P.J., Duchini A., McMillan R., et al. Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection. Am J Gastroenterol 97 (2002) 2040-2045
-
(2002)
Am J Gastroenterol
, vol.97
, pp. 2040-2045
-
-
Pockros, P.J.1
Duchini, A.2
McMillan, R.3
-
19
-
-
0037340514
-
Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection: clinical description of 35 cases
-
Ramos-Casals M., Garcia-Carrasco M., Lopez-Medrano F., et al. Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection: clinical description of 35 cases. Medicine (Baltimore) 82 (2003) 87-96
-
(2003)
Medicine (Baltimore)
, vol.82
, pp. 87-96
-
-
Ramos-Casals, M.1
Garcia-Carrasco, M.2
Lopez-Medrano, F.3
-
20
-
-
21744458711
-
Immune thrombocytopenic purpura in patients with hepatitis C virus infection
-
Nakajima H., Takagi H., Yamazaki Y., et al. Immune thrombocytopenic purpura in patients with hepatitis C virus infection. Hepatogastroenterology 52 (2005) 1197-1200
-
(2005)
Hepatogastroenterology
, vol.52
, pp. 1197-1200
-
-
Nakajima, H.1
Takagi, H.2
Yamazaki, Y.3
-
21
-
-
0031005291
-
Target platelet antigens of autoantibodies in patients with primary biliary cirrhosis
-
Feistauer S.M., Penner E., Mayr W.R., et al. Target platelet antigens of autoantibodies in patients with primary biliary cirrhosis. Hepatology 25 (1997) 1343-1345
-
(1997)
Hepatology
, vol.25
, pp. 1343-1345
-
-
Feistauer, S.M.1
Penner, E.2
Mayr, W.R.3
-
22
-
-
27644498501
-
Pegylated interferon alpha-2a-associated life-threatening Evans' syndrome in a patient with chronic hepatitis C
-
Lambotte O., Gelu-Simeon M., Maigne G., et al. Pegylated interferon alpha-2a-associated life-threatening Evans' syndrome in a patient with chronic hepatitis C. J Infect 51 (2005) e113-e115
-
(2005)
J Infect
, vol.51
-
-
Lambotte, O.1
Gelu-Simeon, M.2
Maigne, G.3
-
23
-
-
13244281650
-
Treatment of immune thrombocytopenia associated with interferon therapy of hepatitis C with the anti-CD20 monoclonal antibody, rituximab
-
Weitz J.C. Treatment of immune thrombocytopenia associated with interferon therapy of hepatitis C with the anti-CD20 monoclonal antibody, rituximab. Am J Hematol 78 (2005) 138-141
-
(2005)
Am J Hematol
, vol.78
, pp. 138-141
-
-
Weitz, J.C.1
-
24
-
-
5044231347
-
Immune thrombocytopenic purpura in a patient treated with interferon alfacon-1
-
Dimitroulopoulos D., Dourakis S.P., Xinopoulos D., et al. Immune thrombocytopenic purpura in a patient treated with interferon alfacon-1. J Viral Hepat 11 (2004) 477-478
-
(2004)
J Viral Hepat
, vol.11
, pp. 477-478
-
-
Dimitroulopoulos, D.1
Dourakis, S.P.2
Xinopoulos, D.3
-
25
-
-
0346749418
-
Possible autoimmune thrombocytopenia associated with pegylated interferon-alpha2a plus ribavarin treatment for hepatitis C
-
Medeiros B.C., Seligman P.A., Everson G.T., et al. Possible autoimmune thrombocytopenia associated with pegylated interferon-alpha2a plus ribavarin treatment for hepatitis C. J Clin Gastroenterol 38 (2004) 84-86
-
(2004)
J Clin Gastroenterol
, vol.38
, pp. 84-86
-
-
Medeiros, B.C.1
Seligman, P.A.2
Everson, G.T.3
-
26
-
-
0242266379
-
Is there an increased frequency of autoimmune thrombocytopenia in hepatitis C infection? A review
-
Panzer S., and Seel E. Is there an increased frequency of autoimmune thrombocytopenia in hepatitis C infection? A review. Wien Med Wochenschr 153 (2003) 417-420
-
(2003)
Wien Med Wochenschr
, vol.153
, pp. 417-420
-
-
Panzer, S.1
Seel, E.2
-
27
-
-
0038238652
-
Life-threatening severe immune thrombocytopenia during alpha-interferon therapy for chronic hepatitis C
-
Fujii H., Kitada T., Yamada T., et al. Life-threatening severe immune thrombocytopenia during alpha-interferon therapy for chronic hepatitis C. Hepatogastroenterology 50 (2003) 841-842
-
(2003)
Hepatogastroenterology
, vol.50
, pp. 841-842
-
-
Fujii, H.1
Kitada, T.2
Yamada, T.3
-
28
-
-
0036118764
-
Autoimmune thrombocytopenia induced by PEG-IFN-alpha2b plus ribavirin in hepatitis C
-
Sagir A., Wettstein M., Heintges T., et al. Autoimmune thrombocytopenia induced by PEG-IFN-alpha2b plus ribavirin in hepatitis C. Dig Dis Sci 47 (2002) 562-563
-
(2002)
Dig Dis Sci
, vol.47
, pp. 562-563
-
-
Sagir, A.1
Wettstein, M.2
Heintges, T.3
-
29
-
-
0032847122
-
Disseminated intravascular coagulation in liver cirrhosis: fact or fiction?
-
Ben-Ari Z., Osman E., Hutton R.A., et al. Disseminated intravascular coagulation in liver cirrhosis: fact or fiction?. Am J Gastroenterol 94 (1999) 2977-2982
-
(1999)
Am J Gastroenterol
, vol.94
, pp. 2977-2982
-
-
Ben-Ari, Z.1
Osman, E.2
Hutton, R.A.3
-
30
-
-
0026661270
-
Disseminated intravascular coagulation in liver cirrhosis
-
Bakker C.M., Knot E.A., Stibbe J., et al. Disseminated intravascular coagulation in liver cirrhosis. J Hepatol 15 (1992) 330-335
-
(1992)
J Hepatol
, vol.15
, pp. 330-335
-
-
Bakker, C.M.1
Knot, E.A.2
Stibbe, J.3
-
31
-
-
0026145737
-
Thrombin activation and increased fibrinolysis in patients with chronic liver disease
-
Paramo J.A., Rifon J., Fernandez J., et al. Thrombin activation and increased fibrinolysis in patients with chronic liver disease. Blood Coagul Fibrinolysis 2 (1991) 227-230
-
(1991)
Blood Coagul Fibrinolysis
, vol.2
, pp. 227-230
-
-
Paramo, J.A.1
Rifon, J.2
Fernandez, J.3
-
32
-
-
0022532735
-
Analysis of elevated fibrin(ogen) degradation product levels in patients with liver disease
-
vanDeWater L., Carr J.M., Aronson D., et al. Analysis of elevated fibrin(ogen) degradation product levels in patients with liver disease. Blood 67 (1986) 1468-1473
-
(1986)
Blood
, vol.67
, pp. 1468-1473
-
-
vanDeWater, L.1
Carr, J.M.2
Aronson, D.3
-
34
-
-
0025026392
-
Incidence and clinical significance of elevated fibrin(ogen) degradation product and/or D-dimer levels in liver cirrhosis patients
-
Cioni G., Cristani A., Mussini C., et al. Incidence and clinical significance of elevated fibrin(ogen) degradation product and/or D-dimer levels in liver cirrhosis patients. Ital J Gastroenterol 22 (1990) 70-74
-
(1990)
Ital J Gastroenterol
, vol.22
, pp. 70-74
-
-
Cioni, G.1
Cristani, A.2
Mussini, C.3
-
35
-
-
0029819726
-
Association between high values of D-dimer and tissue-plasminogen activator activity and first gastrointestinal bleeding in cirrhotic patients. CALC Group
-
Violl F., Basili S., Ferro D., et al. Association between high values of D-dimer and tissue-plasminogen activator activity and first gastrointestinal bleeding in cirrhotic patients. CALC Group. Thromb Haemost 76 (1996) 177-183
-
(1996)
Thromb Haemost
, vol.76
, pp. 177-183
-
-
Violl, F.1
Basili, S.2
Ferro, D.3
-
36
-
-
12444330873
-
Plasma levels of D-dimer and soluble fibrin polymer in patients with hepatocellular carcinoma: a possible predictor of tumor thrombosis
-
Kim H.K., Lee K.R., Yang J.H., et al. Plasma levels of D-dimer and soluble fibrin polymer in patients with hepatocellular carcinoma: a possible predictor of tumor thrombosis. Thromb Res 109 (2003) 125-129
-
(2003)
Thromb Res
, vol.109
, pp. 125-129
-
-
Kim, H.K.1
Lee, K.R.2
Yang, J.H.3
-
37
-
-
0034827797
-
Fat-soluble vitamin levels in patients with primary biliary cirrhosis
-
Phillips J.R., Angulo P., Petterson T., et al. Fat-soluble vitamin levels in patients with primary biliary cirrhosis. Am J Gastroenterol 96 (2001) 2745-2750
-
(2001)
Am J Gastroenterol
, vol.96
, pp. 2745-2750
-
-
Phillips, J.R.1
Angulo, P.2
Petterson, T.3
-
38
-
-
0030612931
-
Plasma vitamin K1 level is decreased in primary biliary cirrhosis
-
Kowdley K.V., Emond M.J., Sadowski J.A., et al. Plasma vitamin K1 level is decreased in primary biliary cirrhosis. Am J Gastroenterol 92 (1997) 2059-2061
-
(1997)
Am J Gastroenterol
, vol.92
, pp. 2059-2061
-
-
Kowdley, K.V.1
Emond, M.J.2
Sadowski, J.A.3
-
39
-
-
0025119535
-
A 21-year experience with major hemorrhage after percutaneous liver biopsy
-
McGill D.B., Rakela J., Zinsmeister A.R., et al. A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology 99 (1990) 1396-1400
-
(1990)
Gastroenterology
, vol.99
, pp. 1396-1400
-
-
McGill, D.B.1
Rakela, J.2
Zinsmeister, A.R.3
-
40
-
-
0024436775
-
Fibrin sealant as a plug for the post liver biopsy needle track
-
Chisholm R.A., Jones S.N., and Lees W.R. Fibrin sealant as a plug for the post liver biopsy needle track. Clin Radiol 40 (1989) 627-628
-
(1989)
Clin Radiol
, vol.40
, pp. 627-628
-
-
Chisholm, R.A.1
Jones, S.N.2
Lees, W.R.3
-
41
-
-
0344515616
-
Plugged-percutaneous liver biopsy in patients with impaired coagulation and ascites
-
Kamphuisen P.W., Wiersma T.G., Mulder C.J., et al. Plugged-percutaneous liver biopsy in patients with impaired coagulation and ascites. Pathophysiol Haemost Thromb 32 (2002) 190-193
-
(2002)
Pathophysiol Haemost Thromb
, vol.32
, pp. 190-193
-
-
Kamphuisen, P.W.1
Wiersma, T.G.2
Mulder, C.J.3
-
42
-
-
18944407713
-
Multiple cycles of recombinant human thrombopoietin therapy in a patient with chronic refractory idiopathic thrombocytopenic purpura
-
Hua B., Zou N., Wang S., et al. Multiple cycles of recombinant human thrombopoietin therapy in a patient with chronic refractory idiopathic thrombocytopenic purpura. Blood Coagul Fibrinolysis 16 (2005) 291-295
-
(2005)
Blood Coagul Fibrinolysis
, vol.16
, pp. 291-295
-
-
Hua, B.1
Zou, N.2
Wang, S.3
-
43
-
-
20244376150
-
A phase I clinical, pharmacologic, and biologic study of thrombopoietin and granulocyte colony-stimulating factor in children receiving ifosfamide, carboplatin, and etoposide chemotherapy for recurrent or refractory solid tumors: a Children's Oncology Group experience
-
Angiolillo A.L., Davenport V., Bonilla M.A., et al. A phase I clinical, pharmacologic, and biologic study of thrombopoietin and granulocyte colony-stimulating factor in children receiving ifosfamide, carboplatin, and etoposide chemotherapy for recurrent or refractory solid tumors: a Children's Oncology Group experience. Clin Cancer Res 11 (2005) 2644-2650
-
(2005)
Clin Cancer Res
, vol.11
, pp. 2644-2650
-
-
Angiolillo, A.L.1
Davenport, V.2
Bonilla, M.A.3
-
44
-
-
0031049879
-
Effects of polyethylene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelet counts after chemotherapy for lung cancer
-
Fanucchi M., Glaspy J., Crawford J., et al. Effects of polyethylene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelet counts after chemotherapy for lung cancer. N Engl J Med 336 (1997) 404-409
-
(1997)
N Engl J Med
, vol.336
, pp. 404-409
-
-
Fanucchi, M.1
Glaspy, J.2
Crawford, J.3
-
45
-
-
0036658131
-
Thrombopoietin as a drug: biologic expectations, clinical realities, and future directions
-
Haznedaroglu I.C., Goker H., Turgut M., et al. Thrombopoietin as a drug: biologic expectations, clinical realities, and future directions. Clin Appl Thromb Hemost 8 (2002) 193-212
-
(2002)
Clin Appl Thromb Hemost
, vol.8
, pp. 193-212
-
-
Haznedaroglu, I.C.1
Goker, H.2
Turgut, M.3
-
46
-
-
0035760892
-
Thrombocytopenia caused by the development of antibodies to thrombopoietin
-
Li J., Yang C., Xia Y., et al. Thrombocytopenia caused by the development of antibodies to thrombopoietin. Blood 98 (2001) 3241-3248
-
(2001)
Blood
, vol.98
, pp. 3241-3248
-
-
Li, J.1
Yang, C.2
Xia, Y.3
-
47
-
-
1642313669
-
Enhanced effect of vascular endothelial growth factor, thrombopoietin peptide agonist, SCF, and Flt3-L on LTC-IC and reporter gene transduction from umbilical cord blood CD34 + cells
-
Smith S.L., Kiss J., Siatskas C., et al. Enhanced effect of vascular endothelial growth factor, thrombopoietin peptide agonist, SCF, and Flt3-L on LTC-IC and reporter gene transduction from umbilical cord blood CD34 + cells. Transfusion 44 (2004) 438-449
-
(2004)
Transfusion
, vol.44
, pp. 438-449
-
-
Smith, S.L.1
Kiss, J.2
Siatskas, C.3
-
48
-
-
19944432021
-
Discovery and characterization of a selective, nonpeptidyl thrombopoietin receptor agonist
-
Erickson-Miller C.L., DeLorme E., Tian S.S., et al. Discovery and characterization of a selective, nonpeptidyl thrombopoietin receptor agonist. Exp Hematol 33 (2005) 85-93
-
(2005)
Exp Hematol
, vol.33
, pp. 85-93
-
-
Erickson-Miller, C.L.1
DeLorme, E.2
Tian, S.S.3
-
49
-
-
0036942861
-
Recombinant human interleukin-11 reduces thrombocytopenia in breast cancer patients receiving tandem autologous circulating progenitor cell transportation
-
Ferrari S., Danova M., Porta C., et al. Recombinant human interleukin-11 reduces thrombocytopenia in breast cancer patients receiving tandem autologous circulating progenitor cell transportation. Ann Hematol 81 (2002) 354-356
-
(2002)
Ann Hematol
, vol.81
, pp. 354-356
-
-
Ferrari, S.1
Danova, M.2
Porta, C.3
-
50
-
-
12344288374
-
Low-dose interleukin-11 in patients with bone marrow failure: update of the M.D. Anderson Cancer Center experience
-
Tsimberidou A.M., Giles F.J., Khouri I., et al. Low-dose interleukin-11 in patients with bone marrow failure: update of the M.D. Anderson Cancer Center experience. Ann Oncol 16 (2005) 139-145
-
(2005)
Ann Oncol
, vol.16
, pp. 139-145
-
-
Tsimberidou, A.M.1
Giles, F.J.2
Khouri, I.3
-
51
-
-
0038036517
-
Recombinant human interleukin-11 improves thrombocytopenia in patients with cirrhosis
-
Ghalib R., Levine C., Hassan M., et al. Recombinant human interleukin-11 improves thrombocytopenia in patients with cirrhosis. Hepatology 37 (2003) 1165-1171
-
(2003)
Hepatology
, vol.37
, pp. 1165-1171
-
-
Ghalib, R.1
Levine, C.2
Hassan, M.3
-
52
-
-
0036952236
-
Interleukin-11 administration normalizes the platelet count in a hypersplenic cirrhotic patient
-
Ustun C., Dainer P.M., and Faguet G.B. Interleukin-11 administration normalizes the platelet count in a hypersplenic cirrhotic patient. Ann Hematol 81 (2002) 609-610
-
(2002)
Ann Hematol
, vol.81
, pp. 609-610
-
-
Ustun, C.1
Dainer, P.M.2
Faguet, G.B.3
-
53
-
-
1642546196
-
Laparoscopic splenectomy reverses thrombocytopenia in patients with hepatitis C cirrhosis and portal hypertension
-
Kercher K.W., Carbonell A.M., Heniford B.T., et al. Laparoscopic splenectomy reverses thrombocytopenia in patients with hepatitis C cirrhosis and portal hypertension. J Gastrointest Surg 8 (2004) 120-126
-
(2004)
J Gastrointest Surg
, vol.8
, pp. 120-126
-
-
Kercher, K.W.1
Carbonell, A.M.2
Heniford, B.T.3
-
54
-
-
0345330205
-
Effects of splenectomy in patients with cirrhosis undergoing hepatic resection for hepatocellular carcinoma
-
Cao Z.X., Chen X.P., and Wu Z.D. Effects of splenectomy in patients with cirrhosis undergoing hepatic resection for hepatocellular carcinoma. World J Gastroenterol 9 (2003) 2460-2463
-
(2003)
World J Gastroenterol
, vol.9
, pp. 2460-2463
-
-
Cao, Z.X.1
Chen, X.P.2
Wu, Z.D.3
-
55
-
-
4444282984
-
Appraisal of concomitant splenectomy in liver resection for hepatocellular carcinoma in cirrhotic patients with hypersplenic thrombocytopenia
-
Wu C.C., Cheng S.B., Ho W.M., et al. Appraisal of concomitant splenectomy in liver resection for hepatocellular carcinoma in cirrhotic patients with hypersplenic thrombocytopenia. Surgery 136 (2004) 660-668
-
(2004)
Surgery
, vol.136
, pp. 660-668
-
-
Wu, C.C.1
Cheng, S.B.2
Ho, W.M.3
-
56
-
-
20044378281
-
Partial splenic embolization in patients with cirrhosis: efficacy, tolerance and long-term outcome in 32 patients
-
N'Kontchou G., Seror O., Bourcier V., et al. Partial splenic embolization in patients with cirrhosis: efficacy, tolerance and long-term outcome in 32 patients. Eur J Gastroenterol Hepatol 17 (2005) 179-184
-
(2005)
Eur J Gastroenterol Hepatol
, vol.17
, pp. 179-184
-
-
N'Kontchou, G.1
Seror, O.2
Bourcier, V.3
-
57
-
-
0027313010
-
Partial splenic embolization for the treatment of hypersplenism in cirrhosis
-
Sangro B., Bilbao I., Herrero I., et al. Partial splenic embolization for the treatment of hypersplenism in cirrhosis. Hepatology 18 (1993) 309-314
-
(1993)
Hepatology
, vol.18
, pp. 309-314
-
-
Sangro, B.1
Bilbao, I.2
Herrero, I.3
-
58
-
-
16344384956
-
An audit of the indications for and techniques of palliative splenic radiotherapy in the UK
-
Jyothirmayi R., and Coltart S. An audit of the indications for and techniques of palliative splenic radiotherapy in the UK. Clin Oncol (R Coll Radiol) 17 (2005) 192-194
-
(2005)
Clin Oncol (R Coll Radiol)
, vol.17
, pp. 192-194
-
-
Jyothirmayi, R.1
Coltart, S.2
-
59
-
-
0030992726
-
Splenic irradiation for the treatment of hypersplenism from congestive splenomegaly
-
Kenawi M.M., el-Ghamrawi K.A., Mohammad A.A., et al. Splenic irradiation for the treatment of hypersplenism from congestive splenomegaly. Br J Surg 84 (1997) 860-861
-
(1997)
Br J Surg
, vol.84
, pp. 860-861
-
-
Kenawi, M.M.1
el-Ghamrawi, K.A.2
Mohammad, A.A.3
-
60
-
-
0028904063
-
Congestive hypersplenism: treatment by means of radioembolization of the spleen with Y-90
-
Becker C.D., Rosler H., Biasiutti F.D., et al. Congestive hypersplenism: treatment by means of radioembolization of the spleen with Y-90. Radiology 195 (1995) 183-186
-
(1995)
Radiology
, vol.195
, pp. 183-186
-
-
Becker, C.D.1
Rosler, H.2
Biasiutti, F.D.3
-
61
-
-
0029897388
-
Prospective evaluation of haematological alterations following the transjugular intrahepatic portosystemic stent-shunt (TIPSS)
-
Jalan R., Redhead D.N., Allan P.L., et al. Prospective evaluation of haematological alterations following the transjugular intrahepatic portosystemic stent-shunt (TIPSS). Eur J Gastroenterol Hepatol 8 (1996) 381-385
-
(1996)
Eur J Gastroenterol Hepatol
, vol.8
, pp. 381-385
-
-
Jalan, R.1
Redhead, D.N.2
Allan, P.L.3
-
62
-
-
0030997274
-
Effect of transjugular intrahepatic portosystemic shunt on secondary hypersplenism
-
Pursnani K.G., Sillin L.F., and Kaplan D.S. Effect of transjugular intrahepatic portosystemic shunt on secondary hypersplenism. Am J Surg 173 (1997) 169-173
-
(1997)
Am J Surg
, vol.173
, pp. 169-173
-
-
Pursnani, K.G.1
Sillin, L.F.2
Kaplan, D.S.3
-
63
-
-
0029148142
-
Course of thrombocytopenia of chronic liver disease after transjugular intrahepatic portosystemic shunts (TIPS). A retrospective analysis
-
Lawrence S.P., Lezotte D.C., and Durham J.D. Course of thrombocytopenia of chronic liver disease after transjugular intrahepatic portosystemic shunts (TIPS). A retrospective analysis. Dig Dis Sci 40 (1995) 1575-1580
-
(1995)
Dig Dis Sci
, vol.40
, pp. 1575-1580
-
-
Lawrence, S.P.1
Lezotte, D.C.2
Durham, J.D.3
-
64
-
-
0030024001
-
Improvement of thrombocytopenia due to hypersplenism after transjugular intrahepatic portosystemic shunt placement in cirrhotic patients
-
Alvarez O.A., Lopera G.A., Patel V., et al. Improvement of thrombocytopenia due to hypersplenism after transjugular intrahepatic portosystemic shunt placement in cirrhotic patients. Am J Gastroenterol 91 (1996) 134-137
-
(1996)
Am J Gastroenterol
, vol.91
, pp. 134-137
-
-
Alvarez, O.A.1
Lopera, G.A.2
Patel, V.3
-
65
-
-
0032960950
-
Course of platelet counts in cirrhotic patients after implantation of a transjugular intrahepatic portosystemic shunt-a prospective, controlled study
-
Gschwantler M., Vavrik J., Gebauer A., et al. Course of platelet counts in cirrhotic patients after implantation of a transjugular intrahepatic portosystemic shunt-a prospective, controlled study. J Hepatol 30 (1999) 254-259
-
(1999)
J Hepatol
, vol.30
, pp. 254-259
-
-
Gschwantler, M.1
Vavrik, J.2
Gebauer, A.3
-
66
-
-
0033732227
-
Effect of transjugular intrahepatic portosystemic shunt on thrombocytopenia associated with cirrhosis
-
Karasu Z., Gurakar A., Kerwin B., et al. Effect of transjugular intrahepatic portosystemic shunt on thrombocytopenia associated with cirrhosis. Dig Dis Sci 45 (2000) 1971-1976
-
(2000)
Dig Dis Sci
, vol.45
, pp. 1971-1976
-
-
Karasu, Z.1
Gurakar, A.2
Kerwin, B.3
-
67
-
-
0031772387
-
Does transjugular intrahepatic portosystemic shunt (TIPS) resolve thrombocytopenia associated with cirrhosis?
-
Jabbour N., Zajko A., Orons P., et al. Does transjugular intrahepatic portosystemic shunt (TIPS) resolve thrombocytopenia associated with cirrhosis?. Dig Dis Sci 43 (1998) 2459-2462
-
(1998)
Dig Dis Sci
, vol.43
, pp. 2459-2462
-
-
Jabbour, N.1
Zajko, A.2
Orons, P.3
-
68
-
-
0034137472
-
The use and misuse of transjugular intrahepatic portasystemic shunts
-
Sanyal A.J. The use and misuse of transjugular intrahepatic portasystemic shunts. Curr Gastroenterol Rep 2 (2000) 61-71
-
(2000)
Curr Gastroenterol Rep
, vol.2
, pp. 61-71
-
-
Sanyal, A.J.1
-
69
-
-
0038649821
-
Role of fresh frozen plasma infusion in correction of coagulopathy of chronic liver disease: a dual phase study
-
Youssef W.I., Salazar F., Dasarathy S., et al. Role of fresh frozen plasma infusion in correction of coagulopathy of chronic liver disease: a dual phase study. Am J Gastroenterol 98 (2003) 1391-1394
-
(2003)
Am J Gastroenterol
, vol.98
, pp. 1391-1394
-
-
Youssef, W.I.1
Salazar, F.2
Dasarathy, S.3
-
70
-
-
0037711915
-
Use of activated recombinant human factor VII (rhFVIIa) for colonic polypectomies in patients with cirrhosis and coagulopathy
-
Anantharaju A., Mehta K., Mindikoglu A.L., et al. Use of activated recombinant human factor VII (rhFVIIa) for colonic polypectomies in patients with cirrhosis and coagulopathy. Dig Dis Sci 48 (2003) 1414-1424
-
(2003)
Dig Dis Sci
, vol.48
, pp. 1414-1424
-
-
Anantharaju, A.1
Mehta, K.2
Mindikoglu, A.L.3
-
71
-
-
0037338514
-
Pericardiocentesis and pancreatic aspiration needle biopsy in coagulopathic and thrombocytopenic cirrhotic patient
-
Mindikoglu A.L., Anantharaju A., Villanueva J., et al. Pericardiocentesis and pancreatic aspiration needle biopsy in coagulopathic and thrombocytopenic cirrhotic patient. Chest 123 (2003) 956-958
-
(2003)
Chest
, vol.123
, pp. 956-958
-
-
Mindikoglu, A.L.1
Anantharaju, A.2
Villanueva, J.3
-
72
-
-
0036302232
-
Safety and efficacy of recombinant factor VIIa in patients with liver disease undergoing laparoscopic liver biopsy
-
Jeffers L., Chalasani N., Balart L., et al. Safety and efficacy of recombinant factor VIIa in patients with liver disease undergoing laparoscopic liver biopsy. Gastroenterology 123 (2002) 118-126
-
(2002)
Gastroenterology
, vol.123
, pp. 118-126
-
-
Jeffers, L.1
Chalasani, N.2
Balart, L.3
-
73
-
-
0037320717
-
Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy
-
Shami V.M., Caldwell S.H., and Hespenheide E.E. Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy. Liver Transpl 9 (2003) 138-143
-
(2003)
Liver Transpl
, vol.9
, pp. 138-143
-
-
Shami, V.M.1
Caldwell, S.H.2
Hespenheide, E.E.3
-
74
-
-
0034863405
-
Recombinant activated factor VII (rFVIIa) acutely normalizes prothrombin time in patients with cirrhosis during bleeding from oesophageal varices
-
Ejlersen E., Melsen T., Ingerslev J., et al. Recombinant activated factor VII (rFVIIa) acutely normalizes prothrombin time in patients with cirrhosis during bleeding from oesophageal varices. Scand J Gastroenterol 36 (2001) 1081-1085
-
(2001)
Scand J Gastroenterol
, vol.36
, pp. 1081-1085
-
-
Ejlersen, E.1
Melsen, T.2
Ingerslev, J.3
-
75
-
-
0842264847
-
Recombinant-activated factor VII as hemostatic therapy in eight cases of severe hemorrhage from esophageal varices
-
Romero-Castro R., Jimenez-Saenz M., Pellicer-Bautista F., et al. Recombinant-activated factor VII as hemostatic therapy in eight cases of severe hemorrhage from esophageal varices. Clin Gastroenterol Hepatol 2 (2004) 78-84
-
(2004)
Clin Gastroenterol Hepatol
, vol.2
, pp. 78-84
-
-
Romero-Castro, R.1
Jimenez-Saenz, M.2
Pellicer-Bautista, F.3
-
76
-
-
5144222624
-
Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial
-
Bosch J., Thabut D., Bendtsen F., et al. Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial. Gastroenterology 127 (2004) 1123-1130
-
(2004)
Gastroenterology
, vol.127
, pp. 1123-1130
-
-
Bosch, J.1
Thabut, D.2
Bendtsen, F.3
-
77
-
-
23744438763
-
Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease
-
Planinsic R.M., van der Meer J., Testa G., et al. Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease. Liver Transpl 11 (2005) 895-900
-
(2005)
Liver Transpl
, vol.11
, pp. 895-900
-
-
Planinsic, R.M.1
van der Meer, J.2
Testa, G.3
-
78
-
-
23744440522
-
Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation
-
Lodge J.P.A., Jonas S., Jones R.M., et al. Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation. Liver Transpl 11 (2005) 973-979
-
(2005)
Liver Transpl
, vol.11
, pp. 973-979
-
-
Lodge, J.P.A.1
Jonas, S.2
Jones, R.M.3
-
79
-
-
0027958326
-
The international normalized ratio
-
Hirsh J., and Poller L. The international normalized ratio. Arch Intern Med 154 (1994) 282-288
-
(1994)
Arch Intern Med
, vol.154
, pp. 282-288
-
-
Hirsh, J.1
Poller, L.2
-
81
-
-
0029912013
-
Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio
-
Robert A., and Chazouilleres O. Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio. Hepatology 24 (1996) 1392-1394
-
(1996)
Hepatology
, vol.24
, pp. 1392-1394
-
-
Robert, A.1
Chazouilleres, O.2
-
82
-
-
0028365539
-
Assessment of the validity of the INR system for patients with liver impairment
-
Kovacs M.H., Wong A., MacKinnon K., et al. Assessment of the validity of the INR system for patients with liver impairment. Thromb Haemost 71 (1994) 727-730
-
(1994)
Thromb Haemost
, vol.71
, pp. 727-730
-
-
Kovacs, M.H.1
Wong, A.2
MacKinnon, K.3
-
83
-
-
0033562928
-
Comparative studies of rabbit and human recombinant tissue factor reagents
-
Denson K.W.E., Reed S.V., Haddon M.E., et al. Comparative studies of rabbit and human recombinant tissue factor reagents. Thromb Res 94 (1999) 255-261
-
(1999)
Thromb Res
, vol.94
, pp. 255-261
-
-
Denson, K.W.E.1
Reed, S.V.2
Haddon, M.E.3
-
84
-
-
4544373091
-
Hemostatic disorders in liver disease
-
Schiff E.R., Sorrell M.F., and Maddrey W.C. (Eds), Lippincott Williams and Wilkins, Philadelphia
-
Hedner U., and Erhardtsen E. Hemostatic disorders in liver disease. In: Schiff E.R., Sorrell M.F., and Maddrey W.C. (Eds). Diseases of the liver (2003), Lippincott Williams and Wilkins, Philadelphia 625-635
-
(2003)
Diseases of the liver
, pp. 625-635
-
-
Hedner, U.1
Erhardtsen, E.2
-
85
-
-
0037223652
-
Model for end-stage liver disease (MELD) and allocation of donor liver
-
Wiesner R., Edwards E., Freeman R., et al. Model for end-stage liver disease (MELD) and allocation of donor liver. Gastroenterology 124 (2003) 91-96
-
(2003)
Gastroenterology
, vol.124
, pp. 91-96
-
-
Wiesner, R.1
Edwards, E.2
Freeman, R.3
-
86
-
-
4544300925
-
Specific laboratory methodologies achieve higher Model for Endstage Liver Disease (MELD) scores for patients listed for liver transplantation
-
R
-
Trotter J.F., Brimhall B., Arjal R., et al. Specific laboratory methodologies achieve higher Model for Endstage Liver Disease (MELD) scores for patients listed for liver transplantation. Liver Transpl (2004) R
-
(2004)
Liver Transpl
-
-
Trotter, J.F.1
Brimhall, B.2
Arjal, R.3
|